Sale!

ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the ITGB3 gene responsible for neonatal alloimmune thrombocytopenia (NAIT). This comprehensive test utilizes next-generation sequencing technology to detect genetic variations that can cause severe platelet disorders in newborns. The test is crucial for families with a history of unexplained bleeding disorders in infants, helping to prevent life-threatening complications. Results provide valuable information for future pregnancy planning and medical management. The test is priced at $500 USD and offers critical insights for hematologists and genetic specialists. Early detection through this advanced genetic screening can significantly improve neonatal outcomes and guide appropriate treatment strategies.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test

Comprehensive Genetic Testing for Neonatal Platelet Disorders

The ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test represents a breakthrough in neonatal hematology diagnostics. This advanced genetic screening test specifically targets the ITGB3 gene, which plays a critical role in platelet function and development. Neonatal alloimmune thrombocytopenia (NAIT) is a serious condition where maternal antibodies attack fetal platelets, potentially leading to life-threatening bleeding complications in newborns.

What This Test Measures and Detects

Our state-of-the-art NGS (Next-Generation Sequencing) technology examines the complete ITGB3 gene sequence to identify:

  • Pathogenic mutations in the ITGB3 gene encoding the β3 integrin subunit
  • Genetic variations associated with platelet glycoprotein IIb/IIIa complex defects
  • Inherited mutations that can cause neonatal alloimmune thrombocytopenia
  • Specific genetic markers that predict antibody-mediated platelet destruction
  • Variants affecting platelet aggregation and clot formation mechanisms

Who Should Consider This Test

This specialized genetic test is recommended for individuals and families experiencing:

  • Unexplained bleeding disorders in newborns or infants
  • Family history of neonatal thrombocytopenia or platelet disorders
  • Previous pregnancies affected by intracranial hemorrhage in newborns
  • Suspected immune-mediated platelet destruction in neonates
  • Recurrent miscarriages with suspected platelet-related complications
  • Planning future pregnancies with known platelet antigen incompatibility risks

Key Benefits of ITGB3 Genetic Testing

  • Early Risk Assessment: Identify genetic predispositions before pregnancy complications occur
  • Personalized Treatment Planning: Guide appropriate medical interventions for affected newborns
  • Family Planning Guidance: Provide crucial information for future pregnancy management
  • Preventive Strategies: Implement targeted monitoring and preventive measures during pregnancy
  • Comprehensive Genetic Counseling: Support informed decision-making for families

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your ITGB3 gene status:

  • Normal Result: No pathogenic mutations detected in the ITGB3 gene sequence
  • Pathogenic Mutation Detected: Identified genetic variation associated with increased NAIT risk
  • Variant of Uncertain Significance: Genetic change requiring additional clinical correlation
  • Carrier Status: Information about inheritance patterns and family risk assessment

All results are accompanied by detailed interpretation from our board-certified genetic specialists and hematologists, providing clear guidance for next steps and management recommendations.

Test Pricing Information

Test Description Price (USD)
ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test – Discount Price $500
ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t leave your family’s health to chance. Our ITGB3 Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test provides the critical information needed to protect your future children from potentially devastating bleeding disorders. With rapid turnaround times of 3-4 weeks and comprehensive genetic counseling support, we make advanced genetic testing accessible and understandable.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our expert genetic counselors are ready to answer your questions and guide you through the testing process.

Remember: Early genetic detection can prevent serious complications and provide peace of mind for your family’s future. Take the first step toward comprehensive neonatal health protection today.